{"id":20497,"date":"2022-11-10T08:17:36","date_gmt":"2022-11-10T13:17:36","guid":{"rendered":"https:\/\/medicarereport.org\/?p=20497"},"modified":"2022-11-10T08:17:37","modified_gmt":"2022-11-10T13:17:37","slug":"depression-and-alzheimers-treatments-at-a-crossroads","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=20497","title":{"rendered":"Depression And Alzheimer&#8217;s Treatments At A Crossroads"},"content":{"rendered":"\n<p>(By Jon Hamilton and Aaron Scott for NPR)<\/p>\n\n\n\n<p>Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer&#8217;s disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.  Listen to the podcast <a href=\"https:\/\/www.npr.org\/2022\/11\/08\/1135146352\/depression-and-alzheimers-treatments-at-a-crossroads\" data-type=\"URL\" data-id=\"https:\/\/www.npr.org\/2022\/11\/08\/1135146352\/depression-and-alzheimers-treatments-at-a-crossroads\">here&#8230;<\/a><\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" width=\"175\" height=\"63\" class=\"wp-image-3902\" style=\"width: 175px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png 152w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo-150x55.png 150w\" sizes=\"auto, (max-width: 175px) 100vw, 175px\" \/><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Notice:<\/strong>&nbsp;The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Jon Hamilton and Aaron Scott for NPR) Researchers are launching a make-or-break study to test the conventional wisdom about<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18,26],"tags":[116,252,251,94],"class_list":["post-20497","post","type-post","status-publish","format-standard","hentry","category-aging","category-alzheimersdementia","tag-alzheimers-disease","tag-alzheimers-treatment","tag-depression","tag-older-adults"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20497","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=20497"}],"version-history":[{"count":2,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20497\/revisions"}],"predecessor-version":[{"id":20499,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20497\/revisions\/20499"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=20497"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=20497"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=20497"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}